Long COVID : New Treatment Perspective Using Nutraceuticals

Loading...
Thumbnail Image
Date
2022-05
Journal Title
Journal ISSN
Volume Title
Publisher
Indian Medical Association
Abstract
Coronavirus disease (COVID-19) is an ongoing worldwide pandemic affecting a large population regardless of gender, age, and ethnicity. The persistence of the COVID-19 symptoms has become a significant health issue and is collectively called “Long COVID.” It can be described as the presence of symptoms of COVID even after the recovery from the viral infection. The prolonged symptoms in the patients could be due to various reasons and factors. Prolonged fatigue is a common symptom of Long COVID in patients even after they have recovered from the viral infection. Currently, only rehabilitation has shown promising results in managing the symptoms of Long COVID. Although pharmaceutical drugs have shown potential in treating the symptoms of Long COVID, more clinical evidence is required to confirm its treatment with less to no side effects; since it’s a new disease, the in-depth knowledge of the same is still evolving. Another healthier approach to treating the symptoms of Long COVID could be dietary supplements or “Nutraceuticals,” identified as an alternative to pharmaceuticals, including nutritional supplements, derived nutrients, and dietary and herbal products that display physiological advantages. Nutritional strategies can also play a role in treating hospitalized patients as maintaining the immune system is critical to combat viral infection.Nutraceuticals may be a practical and healthier approach to managing the symptoms of Long COVID or COVID-19. Although ample clinical evidence is present for the treatment of symptoms of COVID-19, further studies in treating Long COVID or its symptoms are required
Description
Keywords
Long COVID, Headache, Pain, Curcumin, Ginger, Nutraceutical etc
Citation
Thacker Hemant P, Desai Anish. Long COVID : New Treatment Perspective Using Nutraceuticals. Journal of The Indian Medical Association. 2022 May; 120(5): 67-74